IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 11/23/20

IPA Selects Polytope™ Formulations for Pre-Clinical Studies PR Newswire VICTORIA, BC, Nov. 23, 2020 VICTORIA, BC , Nov. 23, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE: TQB2), a...

ImmunoPrecise (IPATF) has entered into a research agreement with Genmab (GMAB), wherein IPA will generate bispecific antibody combinations using Genmab's proprietary DuoBody platform and IPA's proprietary antibodies in the field of infectious disease.As a part of the partnership, Ge...

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease Canada NewsWire VICTORIA, BC, Nov. 19, 2020 VICTORIA, BC , Nov. 19, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (...

ImmunoPrecise Antibodies Confirms Effective Date of Share Consolidation Canada NewsWire VICTORIA, BC, Nov. 17, 2020 VICTORIA, BC , Nov. 17, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the " Company " or " ImmunoPrecise ") (TSXV: IPA) (OTCQB: IPATF) (F...

ImmunoPrecise Antibodies Files Preliminary Base Shelf Prospectus and Registration Statement Canada NewsWire VICTORIA, BC, Nov. 9, 2020 VICTORIA, BC , Nov. 9, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the " Company " or " IPA ") (TSXV: IPA) (OTCQB: I...

ImmunoPrecise Antibodies to Complete Share Consolidation in Preparation for Potential Nasdaq Listing Canada NewsWire VICTORIA, BC, Nov. 4, 2020 VICTORIA, BC , Nov. 4, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the " Company " or " IPA ") (TSXV: IPA) ...

ImmunoPrecise Antibodies and Mila Announce Strategic AI Partnership Canada NewsWire VICTORIA, BC, Nov. 3, 2020 VICTORIA, BC , Nov. 3, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in ...

ImmunoPrecise and Twist Bioscience Announce Collaboration for the Creation of Novel, Therapeutic Products PR Newswire VICTORIA, BC, Oct. 27, 2020 VICTORIA, BC , Oct. 27, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IP...

IMMUNOPRECISE ANTIBODIES (IPATF) updates on their NSERC-funded partnership with the University of Victoria for the generation of a real-time cell-phone based COVID-19 antibody diagnostic test.In May, the company announced partnership objective to develop a colorimetric, easy to use, sali...

IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic Test Canada NewsWire VICTORIA, BC, Oct. 8, 2020 Also signs Definitive Commercial Agreement with University of Victoria VICTORIA, BC , Oct. 8...